00
002901.SHE Double Medical Technology Inc
- Market cap
- CNY 17.2B
- P/E
- 26.2x
- P/B
- 4.68x
- ROE
- 17.6%
- Dividend yield
- 1.25%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 002901.SHE undervalued?
Graham number002901.SHE trades 133.6% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Double Medical Technology Inc fundamental analysis
No fundamental analysis for Double Medical Technology Inc yet.
Double Medical Technology Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Double Medical Technology Inc
Double Medical Technology Inc. engages in the research, development, production, and sale of high-value medical consumables in China. The company offers orthopedic trauma implants, spinal implants, joint implants, sports medicine and neurosurgery implants, minimally invasive surgical implants, and dental implants. It also exports its products. The company was formerly known as Xiamen Da Bo Ying Jing Medical Equipment Company Limited. Double Medical Technology Inc. was incorp…
Full company profileDouble Medical Technology Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Double Medical Technology Inc annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 463M | 594M | 772M | 1.26B | 1.59B | 1.99B | 1.43B | 1.53B | 2.14B | 2.60B | 2.77B |
| Gross Profit | 378M | 491M | 618M | 1.07B | 1.36B | 1.68B | 1.09B | 992M | 1.43B | 1.83B | 2.05B |
| Operating Income | 243M | 351M | 441M | 571M | 715M | 822M | 147M | 103M | 430M | 719M | 832M |
| EBITDA | 260M | 340M | 435M | 530M | 683M | 782M | 117M | 121M | 447M | 873M | 789M |
| Net Income | 219M | 296M | 371M | 465M | 606M | 673M | 92.6M | 59.0M | 357M | 600M | 628M |
| EPS | 0.61 | 0.80 | 0.93 | 1.16 | 1.51 | 1.67 | 0.22 | 0.14 | 0.86 | 1.45 | 1.52 |
| Balance Sheet | |||||||||||
| Total Assets | 719M | 1.39B | 1.67B | 2.24B | 2.65B | 3.38B | 3.94B | 4.64B | 4.42B | 4.92B | 4.84B |
| Total Liabilities | 139M | 150M | 207M | 485M | 512M | 791M | 831M | 1.48B | 1.24B | 1.24B | 1.18B |
| Shareholders' Equity | 574M | 1.23B | 1.44B | 1.72B | 2.10B | 2.51B | 3.00B | 3.06B | 3.08B | 3.57B | 3.56B |
| Cash & Short-term Investments | 228M | 514M | 966M | 923M | 1.07B | 1.18B | 1.35B | 1.66B | 1.25B | 1.22B | 912M |
| Total Debt | - | 4.50M | - | - | 3.90M | 13.6M | 60.9M | 588M | 328M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 207M | 309M | 335M | 434M | 556M | 673M | 128M | 73.9M | 442M | 831M | - |
| Capital Expenditure | 33.3M | 36.9M | 103M | 319M | 137M | 235M | 285M | 306M | 270M | 134M | 140M |
| Free Cash Flow | 174M | 272M | 231M | 115M | 419M | 438M | -157M | -232M | 172M | 698M | 467M |
| Ratios | |||||||||||
| ROE | 38.2% | 24.1% | 25.8% | 27.0% | 28.8% | 26.8% | 3.1% | 1.9% | 11.6% | 16.8% | 17.6% |
| ROA | 30.5% | 21.3% | 22.3% | 20.8% | 22.9% | 19.9% | 2.4% | 1.3% | 8.1% | 12.2% | 13.0% |
| Net Profit Margin | 47.4% | 49.8% | 48.1% | 37.0% | 38.2% | 33.8% | 6.5% | 3.8% | 16.7% | 23.1% | 22.7% |
| Debt to Equity | - | 0.00x | - | - | 0.00x | 0.01x | 0.02x | 0.19x | 0.11x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Double Medical Technology Inc dividends
- Dividend yield
- 1.25%
- Forward dividend
- 0.60 CNY
- Payout ratio
- 35.7%
- Ex-dividend date
- Jul 7, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 214M | 0.52 | 35.7% |
| 2024 | CNY 118M | 0.28 | 33.1% |
| 2023 | CNY 9.43M | 0.02 | 16.0% |
| 2022 | CNY 208M | 0.50 | 225.2% |
| 2021 | CNY 324M | 0.80 | 48.1% |
| 2020 | CNY 241M | 0.60 | 39.8% |
| 2019 | CNY 207M | 0.52 | 44.4% |
| 2018 | CNY 160M | 0.40 | 43.1% |
| 2017 | CNY 96.1M | 0.26 | 32.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Double Medical Technology Inc
- Insiders 82.83%
- Institutions 3.49%
- Public & others 13.69%
- Shares outstanding 414M
- Free float 61.7M
Double Medical Technology Inc company profile
- Company name
- Double Medical Technology Inc
- Ticker
- 002901.SHE
- ISIN
- CNE1000032W7
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 4,704
- Fiscal year end
- December
- Address
- No. 18, Hongdong Road, Xiamen, China, 361027
- Phone
- 86 59 2608 3018
- Website
- double-medical.com
About Double Medical Technology Inc
Double Medical Technology Inc. engages in the research, development, production, and sale of high-value medical consumables in China. The company offers orthopedic trauma implants, spinal implants, joint implants, sports medicine and neurosurgery implants, minimally invasive surgical implants, and dental implants. It also exports its products. The company was formerly known as Xiamen Da Bo Ying Jing Medical Equipment Company Limited. Double Medical Technology Inc. was incorporated in 2004 and is headquartered in Xiamen, China.
Double Medical Technology Inc management
3- Ms. Danhe ChenFinancial Director & Accounting Supervisor · born 1980
- Mr. Xiannan HuaBoard Secretary · born 1983
- Mr. You Cun ChenDeputy General Manager